Shandong Kexing Bioproducts Co,.Ltd (688136.SS)
CNY 21.18
(-1.72%)
CNY 21.18
(-1.72%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.12 Billion CNY | 36.14% |
| 2022 | 1.11 Billion CNY | 14.03% |
| 2021 | 974.79 Million CNY | 23.04% |
| 2020 | 792.23 Million CNY | 4.12% |
| 2019 | 760.91 Million CNY | 31.12% |
| 2018 | 580.34 Million CNY | 50.28% |
| 2017 | 386.17 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 164 Million CNY | -17.46% |
| 2024 Q1 | 234.81 Million CNY | -50.22% |
| 2024 Q2 | 211.92 Million CNY | -9.75% |
| 2023 Q2 | 306.39 Million CNY | 26.17% |
| 2023 FY | 1.51 Billion CNY | 36.14% |
| 2023 Q3 | 217.57 Million CNY | -28.99% |
| 2023 Q1 | 242.85 Million CNY | -23.74% |
| 2023 Q4 | 471.72 Million CNY | 116.8% |
| 2022 Q3 | 307.86 Million CNY | 0.01% |
| 2022 Q2 | 307.84 Million CNY | 73.57% |
| 2022 Q1 | 177.36 Million CNY | -46.08% |
| 2022 FY | 1.11 Billion CNY | 14.03% |
| 2022 Q4 | 318.44 Million CNY | 3.44% |
| 2021 FY | 974.79 Million CNY | 23.04% |
| 2021 Q3 | 229.81 Million CNY | -4.8% |
| 2021 Q4 | 328.91 Million CNY | 43.13% |
| 2021 Q1 | 174.67 Million CNY | -21.36% |
| 2021 Q2 | 241.38 Million CNY | 38.19% |
| 2020 Q3 | -301.45 Million CNY | -275.7% |
| 2020 FY | 792.23 Million CNY | 4.12% |
| 2020 Q4 | 222.13 Million CNY | 173.69% |
| 2020 Q2 | 171.57 Million CNY | -2.79% |
| 2020 Q1 | 176.49 Million CNY | -16.75% |
| 2019 Q3 | -122.58 Million CNY | 0.0% |
| 2019 FY | 760.91 Million CNY | 31.12% |
| 2019 Q4 | 212 Million CNY | 272.95% |
| 2018 FY | 580.34 Million CNY | 50.28% |
| 2017 FY | 386.17 Million CNY | 0.0% |